How it works Semaglutide is a GLP-1 receptor agonist
This dual action is why many people find it to be a highly effective tool for weight management
Liu, X., Zhou, C., Li, Y., Ji, Y., Xu, G., Wang, X., & Yan, J
Trulicity FDA Approval History , (Jan 28, 2021)
Even surveys show how quickly the weight-loss jab became a common household item by mid-2024, as per a Reuters report, roughly one in eight adults in the United States reported having ever used a GLP-1 drug, and the proportion using them continues to climb.To everyones bewilderment, that shift of a medicinal drug to a fat-loss jab dug its teeth deep, and now it has produced a market and a culture where the new social expectation is all about the right size.Here, the pattern is somewhat familiar: a pharmaceutical innovation meeting social norms, evolving according to its ingrained insecurities, moulding itself to make room for the same, and finally giving in to accommodate the new definition of social desire.Add social medias visual economy and celebrity signals to the mix, and an experimental therapy becomes a trend.See how the line bends as per the patriarchys will